Antibody Drug Conjugate Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2020 – 2030

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Antibody Drug Conjugate Market Year-on-Year Growth, 2021 – 2030 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook, and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Antibody Drug Conjugate Market by Technology: Market Size and Forecast, 2020 - 2030 

4.1  Overview

4.2  Cleavable Linker

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2020 - 2030 ($ Million)

4.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.3  Non-cleavable Linker

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2020 - 2030 ($ Million)

4.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.4  Linkerless

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2020 - 2030 ($ Million)

4.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

Chapter 5        Global Antibody Drug Conjugate Market by Application: Market Size and Forecast, 2020-2030

5.1  Overview

5.2  Blood Cancer

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.3  Breast Cancer

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.4  Ovarian Cancer

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.5  Urothelial Cancer & Bladder Cancer

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.5.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.6  Lung Cancer

5.6.1   Current Trend and Analysis

5.6.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.6.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.7  Others

5.7.1   Current Trend and Analysis

5.7.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.7.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

Chapter 6    Global Antibody Drug Conjugate Market by End-Use: Market Size and Forecast, 2020 – 2030 

6.1  Overview

6.2  Hospitals & Clinics

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2020 - 2030 ($ Million)

6.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

6.3  Research Institutes

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2020 - 2030 ($ Million)

6.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

6.4  Others

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2020 - 2030 ($ Million)

6.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

Chapter 7        Global Antibody Drug Conjugate Market by Geography: Market Size and Forecast, 2020 – 2030 (%) 

7.1  Overview

7.1.1   Global Antibody Drug Conjugate Market Year-on-Year Growth, by region 2021 – 2030 (%)

7.2  North America

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.3   U.S.

7.2.3.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.3.2        By Technology

7.2.3.3        By Application

7.2.3.4        By End Use

7.2.4   Canada

7.2.4.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.4.2        By Technology

7.2.4.3        By Application

7.2.4.4        By End Use

7.2.5   Mexico

7.2.5.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.5.2        By Technology

7.2.5.3        By Application

7.2.5.4        By End Use

7.3    Europe

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.3   UK

7.3.3.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.3.2        By Technology

7.3.3.3        By Application

7.3.3.4        By End Use

7.3.4   Russia

7.3.4.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.4.2        By Technology

7.3.4.3        By Application

7.3.4.4        By End Use

7.3.5   France

7.3.5.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.5.2        By Technology

7.3.5.3        By Application

7.3.5.4        By End Use

7.3.6   Italy

7.3.6.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.6.2        By Technology

7.3.6.3        By Application

7.3.6.4        By End Use

7.3.7   Germany

7.3.7.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.7.2        By Technology

7.3.7.3        By Application

7.3.7.4        By End Use

7.3.8   Rest of Europe

7.3.8.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.8.2        By Technology

7.3.8.3        By Application

7.3.8.4        By End Use

7.4    Asia-Pacific

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.3   China

7.4.3.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.3.2        By Technology

7.4.3.3        By Application

7.4.3.4        By End Use

7.4.4   India

7.4.4.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.4.2        By Technology

7.4.4.3        By Application

7.4.4.4        By End Use

7.4.5   Japan

7.4.5.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.5.2        By Technology

7.4.5.3        By Application

7.4.5.4        By End Use

7.4.6   Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.6.2        By Technology

7.4.6.3        By Application

7.4.6.4        By End Use

7.5    RoW

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast, 2020 - 2030 ($ Million)

7.5.3   South & Central America

7.5.3.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.5.3.2        By Technology

7.5.3.3        By Application

7.5.3.4        By End Use

7.5.4   Middle East

7.5.4.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.5.4.2        By Technology

7.5.4.3        By Application

7.5.4.4        By End Use

7.5.5   Africa

7.5.5.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.5.5.2        By Technology

7.5.5.3        By Application

7.5.5.4        By End Use

Chapter 8        Company Profiles

8.1  Takeda Pharmaceutical Company Ltd.

8.1.1     Company Overview

8.1.2     Product Portfolio

8.1.3     Business Strategies

8.1.4     Financials

8.1.5     Recent Developments

8.2  Pfizer, Inc.

8.2.1     Company Overview

8.2.2     Product Portfolio

8.2.3     Business Strategies

8.2.4     Financials

8.2.5     Recent Developments

8.3  GlaxoSmithKline Plc.

8.3.1     Company Overview

8.3.2     Product Portfolio

8.3.3     Business Strategies

8.3.4     Financials

8.3.5     Recent Developments

8.4  AstraZeneca.

8.4.1     Company Overview

8.4.2     Product Portfolio

8.4.3     Business Strategies

8.4.4     Financials

8.4.5     Recent Developments

8.5  Gilead Sciences, Inc.

8.5.1     Company Overview

8.5.2     Product Portfolio

8.5.3     Business Strategies

8.5.4     Financials

8.5.5     Recent Developments

8.6  Sanofi S.A.

8.6.1     Company Overview

8.6.2     Product Portfolio

8.6.3     Business Strategies

8.6.4     Financials

8.6.5     Recent Developments

8.7  Daiichi Sankyo Company Ltd.

8.7.1     Company Overview

8.7.2     Product Portfolio

8.7.3     Business Strategies

8.7.4     Financials

8.7.5     Recent Developments

8.8  ADC Therapeutics

8.8.1     Company Overview

8.8.2     Product Portfolio

8.8.3     Business Strategies

8.8.4     Financials

8.8.5     Recent Developments

8.9  Seattle Genetics Inc

8.9.1     Company Overview

8.9.2     Product Portfolio

8.9.3     Business Strategies

8.9.4     Financials

8.9.5     Recent Developments

8.10   Novartis AG.

8.10.1   Company Overview

8.10.2   Product Portfolio

8.10.3   Business Strategies

8.10.4   Financials

8.10.5   Recent Developments

8.11 Others

8.11.1   Company Overview

8.11.2   Product Portfolio

8.11.3   Business Strategies

8.11.4   Financials

8.11.5   Recent Developments